Largazole inhibits ocular angiogenesis by modulating the expression of VEGFR2 and p21
Ocular angiogenic diseases, characterized by abnormal blood vessel formation in the eye, are the leading cause of blindness. Although Anti-VEGF therapy is the first-line treatment in the market, a substantial number of patients are refractory to it or may develop resistance over time. As uncontrolle...
| Huvudupphovsmän: | , , , , , |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Journal Article |
| Språk: | English |
| Publicerad: |
2022
|
| Ämnen: | |
| Länkar: | https://hdl.handle.net/10356/154015 |